Oncternal Therapeutics (NASDAQ: ONCT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.
The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by HC Wainwright & Co. on Wednesday, August 10, 2022. The analyst firm set a price target for 7.00 expecting ONCT to rise to within 12 months (a possible 516.74% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $1.135 last updated Today at August 11, 2022, 5:07 PM UTC.
There are no upcoming dividends for Oncternal Therapeutics.
Oncternal Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Oncternal Therapeutics.
Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.